Trastuzumab Emtansine is the new cancer drug developed by Roche. Unfortunately it costs £90,000 for an extra six months of life per patient and the NHS have decided that it's too expensive. Pressure is being put on Roche to lower prices.
26% of Doctors are non-British in NHS hospitals. This causes some concern as they may not be as highly qualified or as able as people who get turned away at interview in the UK (cough can we have more places for Med School, seriously, please let me in).
Imperial have done several statistical health maps. It's pretty interesting to look at:
Full posts shall resume shortly
